Form 10-Q NEOGENOMICS INC For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Neogenomics (NEO) PT Lowered to $21 at BTIG
May 2, 2024 5:24 AM EDTBTIG analyst Mark Massaro lowered the price target on Neogenomics (NASDAQ: NEO) to $21.00 (from $23.00) while maintaining a Buy rating.
The analyst comments "In this note, we update our NEO model following the company's Q1 call. NEO delivered a good 4% beat on the top line, delivered another quarter of positive Adj. EBITDA, and reiterated... More
